Canadian Cancer Trials Group Bulletins

Trial Management Group

Permanent Trial Closure

Canadian Cancer Trials Group MA.14 -- A Randomized Trial of Antiestrogen Therapy versus Combined Antiestrogen and Octreotide LAR Therapy in the Adjuvant Treatment of Breast Cancer in Post-Menopausal Women -- was permanently closed as of Friday, April 23, 2010.

The notification letter was posted on the MA.14 web page, and centres were notified.